Weekly highlight of top insider buys: Philip Morris International Inc. (PM, Financial), General Motors Company (GM, Financial), Chesapeake Energy Group (CHK, Financial), Valeant Pharmaceuticals International (VRX, Financial), and Marvell Technology Group Ltd. (MRVL, Financial).
Philip Morris International Inc. (PM): Director Sergio Marchionne Bought 1,200 Shares
Director of Philip Morris International Inc., Sergio Marchionne, bought 1,200 shares on 3/07/2011 at an average price of $63.78.
Philip Morris International is the international tobacco company, with products sold in over 160 countries. Philip Morris International Inc. has a market cap of $114.62 billion; its shares were traded at around $63.78 with a P/E ratio of 16.4 and P/S ratio of 1.7. The dividend yield of Philip Morris International Inc. stocks is 4%.
On February 10, Philip Morris International Inc. reported results for the full year and fourth quarter of 2010. For the year, reported diluted earnings per share was $3.92, up by 21.0%, or by 17.3% excluding currency, versus $3.24 in 2009. Reported operating companies income was up by 11.6% to $11.5 billion, or by 8.3% excluding currency. For the fourth quarter, eported diluted earnings per share were $0.96, up by 20.0%, or by 18.8% excluding currency, versus $0.80 in 2009 . Reported net revenues, excluding excise taxes, were up by 4.8% to $7.0 billion, or by 5.4% excluding currency, driven by favorable pricing of $580 million
Philip Morris International Inc. is in the portfolios of Joel Greenblatt, Kenneth Fisher, James barrow, Tom Gayner, Donald Yacktman, Jean-Marie Eveillard, Mario Gabelli, Ronald Muhlenkamp, Tweedy Browne, George Soros, Chris Davis, David Winters, David Dreman, NWQ Managers, and Hotchkis & Wiley.
This month, Buy: Director Sergio Marchionne bought 1,200 shares of PM stock. Sell: VP Finance & Treasurer Marco Kuepfer sold 1,751 shares last month. Sell: Chairman and CEO Louis C Camilleri sold shares in September.
General Motors Company (GM): Director E Neville Isdell Bought 7,500 Shares
Director of General Motors Company, E Neville Isdell, bought 7,500 shares on 3/04/2011 at an average price of $31.93.
General Motors Company is engaged in the designing, manufacturing and retailing of vehicles globally including passenger cars, crossover vehicles, and light trucks, sport utility vehicles, vans and other vehicles. General Motors Company has a market cap of $49.83 billion; its shares were traded at around $31.93 with and P/S ratio of 0.4.
On February 24, General Motors Company (NYSE: GM) today announced its calendar year 2010 results marked by $4.7 billion of net income attributable to common stockholders for its first full year of operations. Revenue for the calendar year was $135.6 billion. Automotive cash flow from operating activities was $6.6 billion and automotive free cash flow was $2.4 billion, both reflecting the impact of a $4.0 billion voluntary cash contribution to the company’s U.S. pension plans.
General Motors Company is in the portfolios of Bill Ackman, Richard Perry, David Tepper, Brian Rogers, John Griffin, George Soros, Ken Heebner, Arnold Schneider, Jean-Marie Eveillard, Mario Gabelli, Richard Perry, and Ronald Muhlenkamp.
Buy: CEO Daniel F Akerson, Buy: Director Robert D Krebs, Buy: Director Philip A Laskawy, and Buy: Director E Neville Isdell bought shares of GM stock this month. Buy: Vice President Joel Ewanick and Buy: Vice President Selim Bingol bought shares in November.
Chesapeake Energy Group (CHK): Director Richard K Davidson Bought 20,000 Shares
Director of Chesapeake Energy Group, Richard K Davidson, bought 20,000 shares on 3/10/2011 at an average price of $32.81.
Chesapeake Energy Corp. is an independent oil and gas company engaged in the development, exploration, acquisition and production of onshore natural gas and oil reserves. Chesapeake Energy Corp. has a market cap of $21.45 billion; its shares were traded at around $32.81 with a P/E ratio of 11 and P/S ratio of 2.2. The dividend yield of Chesapeake Energy Corp. stocks is 0.9%. Chesapeake Energy Corp. had an annual average earnings growth of 14.7% over the past 10 years. GuruFocus rated Chesapeake Energy Corp. the business predictability rank of 2-star.
On February 22, Chesapeake Energy Corporation (NYSE:CHK) today announced financial and operational results for the 2010 fourth quarter and full year. For the 2010 fourth quarter, Chesapeake reported net income to common stockholders of $180 million ($0.28 per fully diluted common share) and operating cash flow (defined as cash flow from operating activities before changes in assets and liabilities) of $1.186 billion on revenue of $1.975 billion and production of 269 billion cubic feet of natural gas equivalent (bcfe). For the 2010 full year, Chesapeake reported net income to common stockholders of $1.663 billion ($2.51 per fully diluted common share) and operating cash flow of $4.548 billion on revenue of $9.366 billion and production of 1.035 trillion cubic feet of natural gas equivalent (tcfe). Chesapeake Energy Corp. is in the portfolios of Richard Snow, Carl Icahn, T Boone Pickens, Charles Brandes, Mason Hawkins, George Soros, Ronald Muhlenkamp, Arnold Schneider, David Dreman, Mario Gabelli, and Ruane Cunniff.
This month, Buy: Director V Burns Hargis, Buy: Director Richard K Davidson, Buy: Director Merrill A Jr Miller, and Buy: Chairman & CEO Aubrey K Mcclendon bought shares of CHK stock.
Valeant Pharmaceuticals International (VRX): Director Norma Ann Provencio Bought 1,575 Shares
Director of Valeant Pharmaceuticals International, Norma Ann Provencio, bought 1,575 shares on 3/04/2011 at an average price of $40.07.
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International has a market cap of $12.19 billion; its shares were traded at around $40.07 with a P/E ratio of 36.4 and P/S ratio of 10.2. The dividend yield of Valeant Pharmaceuticals International stocks is 1%. Valeant Pharmaceuticals International had an annual average earnings growth of 10.8% over the past 5 years.
On Feb. 24, Valeant Pharmaceuticals International, Inc. announced fourth quarter financial results for 2010. Total reported revenue was $514.6 million in the fourth quarter of 2010 as compared to $241.1 million in the fourth quarter of 2009. Product sales were $488.7 million in the fourth quarter of 2010, as compared to $231.6 million in the year-ago quarter. These increases are primarily due to the acquisition of Valeant Pharmaceuticals International (Legacy Valeant) by Biovail Corporation (Legacy Biovail), which was completed in September 2010. In connection with the acquisition, Biovail was renamed Valeant Pharmaceuticals International, Inc. Results for the fourth quarter of 2009 only reflect Legacy Biovail revenues and do not include any revenues from Legacy Valeant. Pro forma organic growth for the combined company was approximately six percent for 2010.
Valeant Pharmaceuticals International is in the portfolios of Julian Robertson, George Soros, NWQ Managers, Andreas Halvorsen, John Griffin, Jean-Marie Eveillard, Ruane Cunniff, John Hussman, and Private Capital.
Last week Buy: Director Norma Ann Provencio bought 1,575 shares of VRX stock. Buy: Director Katharine Berghuis Stevenson bought 3,000 shares in November. Sell: Director Robert Alexander Ingram sold 9,872 shares in February; Sell: Director William Mcdowall Wells and Sell: President & COO Spec. Pharma. Silva Rajiv De sold shares in December.
Marvell Technology Group Ltd. (MRVL): Director John G Kassakian Bought 2,000 Shares
Director of Marvell Technology Group Ltd., John G Kassakian, bought 2,000 shares on 3/10/2011 at an average price of $15.67.
Marvell Technology is a designer, developer and supplier of mixed-signal and digital signal processing integrated circuit for high-speed, high-density, digital data storage and broadband digital data networking markets. Marvell Technology Group Ltd. has a market cap of $10.19 billion; its shares were traded at around $15.67 with a P/E ratio of 10.8 and P/S ratio of 2.9. Marvell Technology Group Ltd. had an annual average earnings growth of 34% over the past 10 years.
On Mar 3, 2011 Marvell reported financial results for the fourth fiscal quarter and fiscal year 2011, ended January 29, 2011. Revenue for the fourth quarter of fiscal 2011 was $901 million, a 7 percent increase from $843 million in the fourth quarter of fiscal 2010, ended January 30, 2010, and a 6 percent sequential decrease from $959 million in the third quarter of fiscal 2011, ended October 30, 2010. For the fiscal year ended January 29, 2011, revenue was $3.61 billion, an increase of 29 percent over revenue of$2.81 billion for the fiscal year ended January 30, 2010.
Marvell Technology Group Ltd. is in the portfolios of Joel Greenblatt, George Soros, and lee Ainslie.
This month, Buy: Director John G Kassakian bought 2,000 shares of MRVL stock.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
Philip Morris International Inc. (PM): Director Sergio Marchionne Bought 1,200 Shares
Director of Philip Morris International Inc., Sergio Marchionne, bought 1,200 shares on 3/07/2011 at an average price of $63.78.
Philip Morris International is the international tobacco company, with products sold in over 160 countries. Philip Morris International Inc. has a market cap of $114.62 billion; its shares were traded at around $63.78 with a P/E ratio of 16.4 and P/S ratio of 1.7. The dividend yield of Philip Morris International Inc. stocks is 4%.
On February 10, Philip Morris International Inc. reported results for the full year and fourth quarter of 2010. For the year, reported diluted earnings per share was $3.92, up by 21.0%, or by 17.3% excluding currency, versus $3.24 in 2009. Reported operating companies income was up by 11.6% to $11.5 billion, or by 8.3% excluding currency. For the fourth quarter, eported diluted earnings per share were $0.96, up by 20.0%, or by 18.8% excluding currency, versus $0.80 in 2009 . Reported net revenues, excluding excise taxes, were up by 4.8% to $7.0 billion, or by 5.4% excluding currency, driven by favorable pricing of $580 million
Philip Morris International Inc. is in the portfolios of Joel Greenblatt, Kenneth Fisher, James barrow, Tom Gayner, Donald Yacktman, Jean-Marie Eveillard, Mario Gabelli, Ronald Muhlenkamp, Tweedy Browne, George Soros, Chris Davis, David Winters, David Dreman, NWQ Managers, and Hotchkis & Wiley.
This month, Buy: Director Sergio Marchionne bought 1,200 shares of PM stock. Sell: VP Finance & Treasurer Marco Kuepfer sold 1,751 shares last month. Sell: Chairman and CEO Louis C Camilleri sold shares in September.
General Motors Company (GM): Director E Neville Isdell Bought 7,500 Shares
Director of General Motors Company, E Neville Isdell, bought 7,500 shares on 3/04/2011 at an average price of $31.93.
General Motors Company is engaged in the designing, manufacturing and retailing of vehicles globally including passenger cars, crossover vehicles, and light trucks, sport utility vehicles, vans and other vehicles. General Motors Company has a market cap of $49.83 billion; its shares were traded at around $31.93 with and P/S ratio of 0.4.
On February 24, General Motors Company (NYSE: GM) today announced its calendar year 2010 results marked by $4.7 billion of net income attributable to common stockholders for its first full year of operations. Revenue for the calendar year was $135.6 billion. Automotive cash flow from operating activities was $6.6 billion and automotive free cash flow was $2.4 billion, both reflecting the impact of a $4.0 billion voluntary cash contribution to the company’s U.S. pension plans.
General Motors Company is in the portfolios of Bill Ackman, Richard Perry, David Tepper, Brian Rogers, John Griffin, George Soros, Ken Heebner, Arnold Schneider, Jean-Marie Eveillard, Mario Gabelli, Richard Perry, and Ronald Muhlenkamp.
Buy: CEO Daniel F Akerson, Buy: Director Robert D Krebs, Buy: Director Philip A Laskawy, and Buy: Director E Neville Isdell bought shares of GM stock this month. Buy: Vice President Joel Ewanick and Buy: Vice President Selim Bingol bought shares in November.
Chesapeake Energy Group (CHK): Director Richard K Davidson Bought 20,000 Shares
Director of Chesapeake Energy Group, Richard K Davidson, bought 20,000 shares on 3/10/2011 at an average price of $32.81.
Chesapeake Energy Corp. is an independent oil and gas company engaged in the development, exploration, acquisition and production of onshore natural gas and oil reserves. Chesapeake Energy Corp. has a market cap of $21.45 billion; its shares were traded at around $32.81 with a P/E ratio of 11 and P/S ratio of 2.2. The dividend yield of Chesapeake Energy Corp. stocks is 0.9%. Chesapeake Energy Corp. had an annual average earnings growth of 14.7% over the past 10 years. GuruFocus rated Chesapeake Energy Corp. the business predictability rank of 2-star.
On February 22, Chesapeake Energy Corporation (NYSE:CHK) today announced financial and operational results for the 2010 fourth quarter and full year. For the 2010 fourth quarter, Chesapeake reported net income to common stockholders of $180 million ($0.28 per fully diluted common share) and operating cash flow (defined as cash flow from operating activities before changes in assets and liabilities) of $1.186 billion on revenue of $1.975 billion and production of 269 billion cubic feet of natural gas equivalent (bcfe). For the 2010 full year, Chesapeake reported net income to common stockholders of $1.663 billion ($2.51 per fully diluted common share) and operating cash flow of $4.548 billion on revenue of $9.366 billion and production of 1.035 trillion cubic feet of natural gas equivalent (tcfe). Chesapeake Energy Corp. is in the portfolios of Richard Snow, Carl Icahn, T Boone Pickens, Charles Brandes, Mason Hawkins, George Soros, Ronald Muhlenkamp, Arnold Schneider, David Dreman, Mario Gabelli, and Ruane Cunniff.
This month, Buy: Director V Burns Hargis, Buy: Director Richard K Davidson, Buy: Director Merrill A Jr Miller, and Buy: Chairman & CEO Aubrey K Mcclendon bought shares of CHK stock.
Valeant Pharmaceuticals International (VRX): Director Norma Ann Provencio Bought 1,575 Shares
Director of Valeant Pharmaceuticals International, Norma Ann Provencio, bought 1,575 shares on 3/04/2011 at an average price of $40.07.
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International has a market cap of $12.19 billion; its shares were traded at around $40.07 with a P/E ratio of 36.4 and P/S ratio of 10.2. The dividend yield of Valeant Pharmaceuticals International stocks is 1%. Valeant Pharmaceuticals International had an annual average earnings growth of 10.8% over the past 5 years.
On Feb. 24, Valeant Pharmaceuticals International, Inc. announced fourth quarter financial results for 2010. Total reported revenue was $514.6 million in the fourth quarter of 2010 as compared to $241.1 million in the fourth quarter of 2009. Product sales were $488.7 million in the fourth quarter of 2010, as compared to $231.6 million in the year-ago quarter. These increases are primarily due to the acquisition of Valeant Pharmaceuticals International (Legacy Valeant) by Biovail Corporation (Legacy Biovail), which was completed in September 2010. In connection with the acquisition, Biovail was renamed Valeant Pharmaceuticals International, Inc. Results for the fourth quarter of 2009 only reflect Legacy Biovail revenues and do not include any revenues from Legacy Valeant. Pro forma organic growth for the combined company was approximately six percent for 2010.
Valeant Pharmaceuticals International is in the portfolios of Julian Robertson, George Soros, NWQ Managers, Andreas Halvorsen, John Griffin, Jean-Marie Eveillard, Ruane Cunniff, John Hussman, and Private Capital.
Last week Buy: Director Norma Ann Provencio bought 1,575 shares of VRX stock. Buy: Director Katharine Berghuis Stevenson bought 3,000 shares in November. Sell: Director Robert Alexander Ingram sold 9,872 shares in February; Sell: Director William Mcdowall Wells and Sell: President & COO Spec. Pharma. Silva Rajiv De sold shares in December.
Marvell Technology Group Ltd. (MRVL): Director John G Kassakian Bought 2,000 Shares
Director of Marvell Technology Group Ltd., John G Kassakian, bought 2,000 shares on 3/10/2011 at an average price of $15.67.
Marvell Technology is a designer, developer and supplier of mixed-signal and digital signal processing integrated circuit for high-speed, high-density, digital data storage and broadband digital data networking markets. Marvell Technology Group Ltd. has a market cap of $10.19 billion; its shares were traded at around $15.67 with a P/E ratio of 10.8 and P/S ratio of 2.9. Marvell Technology Group Ltd. had an annual average earnings growth of 34% over the past 10 years.
On Mar 3, 2011 Marvell reported financial results for the fourth fiscal quarter and fiscal year 2011, ended January 29, 2011. Revenue for the fourth quarter of fiscal 2011 was $901 million, a 7 percent increase from $843 million in the fourth quarter of fiscal 2010, ended January 30, 2010, and a 6 percent sequential decrease from $959 million in the third quarter of fiscal 2011, ended October 30, 2010. For the fiscal year ended January 29, 2011, revenue was $3.61 billion, an increase of 29 percent over revenue of$2.81 billion for the fiscal year ended January 30, 2010.
Marvell Technology Group Ltd. is in the portfolios of Joel Greenblatt, George Soros, and lee Ainslie.
This month, Buy: Director John G Kassakian bought 2,000 shares of MRVL stock.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
